Author:
Omar Abdelsattar M.,El-Araby Moustafa E.,Abdelghany Tamer M.,Safo Martin K.,Ahmed Mostafa H.,Boothello Rio,Patel Bhaumik B,Abdel-Bakky Mohamed S.,Malebari Azizah M.,Ahmed Hany E.A.,Elhaggar Radwan S.
Funder
Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, the Kingdom of Saudi Arabia
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference38 articles.
1. Michael acceptors as a tool for anticancer drug design;Ahn;Curr. Pharm. Des.,1996
2. Reversible Michael additions: covalent inhibitors and prodrugs;Johansson;Mini-Rev. Med. Chem.,2012
3. Recent advances in design of new urease inhibitors: A review;Kafarski;J. Adv. Res.,2018
4. BIBW-2992, a dual receptor tyrosine kinase inhibitor for the treatment of solid tumors;Minkovsky;Curr Opin Investig Drugs.,2008
5. Antitumor effect of afatinib, as a human epidermal growth factor receptor 2-targeted therapy, in lung cancers harboring HER2 oncogene alterations;Suzawa;Cancer Sci.,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献